 |
 |
Important Notice: The Forum does not endorse any medical
product or therapy. ALL medications and supplements
should be taken ONLY under the supervision of a physician,
due to the possibility of side-effects, drug interactions,
etc.
|
Animal Model:
|
Neonatal Ventral Hippocampal Lesion
|
|
Preparation Type:
|
Lesion Preparations
|
|
DA-related behavior:
|
Enhanced locomotor responses to amphetamine with
post-pubertal onset; enhanced meth-amphetamine
self-administration
|
|
Gating:
|
Disrupted PPI; prolonged N40 latency
|
|
Cognitive behavior:
|
Various impairments in learning and memory (including
set-shifting and spatial working memory)
|
|
Social behavior:
|
Impaired social behavior
|
|
Molecular/morphological signature:
|
Reduced presynaptic protein and growth factor expression,
reduced NMDA receptor expression, impaired DA receptor
expression in frontal cortex; impaired maturation of PFC;
brain region- and age-specific changes in GABAA receptor
expression; reduced PFC spine density; enhanced sensitivity
to nicotine; increased prefrontal DA output
|
|
Response to APD:
|
Locomotor responses blocked by APD, social impairments
blocked by clozapine but not haloperidol; clozapine
reversed enhanced novelty-induced locomotor activity and
rescued neuronal atrophy in the prefrontal cortex and
nucleus accumbens
|
|
Citations:
|
Lipska BK, Weinberger DR. To model a psychiatric disorder in
animals: schizophrenia as a reality test.
Neuropsychopharmacology . 2000 Sep 1 ; 23(3):223-39. Abstract
Lipska BK. Using animal models to test a
neurodevelopmental hypothesis of schizophrenia. J Psychiatry
Neurosci . 2004 Jul ; 29(4):282-6. Abstract
Tseng KY, Amin F, Lewis BL, O'Donnell P. Altered
prefrontal cortical metabolic response to mesocortical
activation in adult animals with a neonatal ventral
hippocampal lesion. Biol Psychiatry . 2006 Sep 15 ;
60(6):585-90. Abstract
Tseng KY, Lewis BL, Lipska BK, O'Donnell P.
Post-pubertal disruption of medial prefrontal cortical
dopamine-glutamate interactions in a developmental animal
model of schizophrenia. Biol Psychiatry . 2007 Oct 1 ;
62(7):730-8. Abstract
Tseng KY, Lewis BL, Hashimoto T, Sesack SR, Kloc M,
Lewis DA, O'Donnell P. A neonatal ventral hippocampal lesion
causes functional deficits in adult prefrontal cortical
interneurons. J Neurosci . 2008 Nov 26 ; 28(48):12691-9. Abstract
Endo K, Hori T, Abe S, Asada T. Alterations in
GABA(A) receptor expression in neonatal ventral hippocampal
lesioned rats: comparison of prepubertal and postpubertal
periods. Synapse . 2007 Jun 1 ; 61(6):357-66. Abstract
Marquis JP, Goulet S, Doré FY. Neonatal ventral
hippocampus lesions disrupt extra-dimensional shift and
alter dendritic spine density in the medial prefrontal
cortex of juvenile rats. Neurobiol Learn Mem . 2008 Sep 1 ;
90(2):339-46. Abstract
Brady AM, McCallum SE, Glick SD, O'Donnell P.
Enhanced methamphetamine self-administration in a
neurodevelopmental rat model of schizophrenia.
Psychopharmacology (Berl) . 2008 Oct 1 ; 200(2):205-15. Abstract
Berg SA, Chambers RA. Accentuated behavioral
sensitization to nicotine in the neonatal ventral
hippocampal lesion model of schizophrenia. Neuropharmacology
. 2008 Jun 1 ; 54(8):1201-7. Abstract
Brady AM. Neonatal ventral hippocampal lesions
disrupt set-shifting ability in adult rats. Behav Brain Res
. 2009 Dec 14 ; 205(1):294-8. Abstract
Vohs JL, Chambers RA, Krishnan GP, O'Donnell BF,
Hetrick WP, Kaiser ST, Berg S, Morzorati SL. Auditory
sensory gating in the neonatal ventral hippocampal lesion
model of schizophrenia. Neuropsychobiology . 2009 ;
60(1):12-22. Abstract
Brady AM, Saul RD, Wiest MK. Selective deficits in
spatial working memory in the neonatal ventral hippocampal
lesion rat model of schizophrenia. Neuropharmacology . 2010
Dec ; 59(7-8):605-11.
Abstract
Macedo CE, Angst MJ, Gobaille S, Schleef C, Guignard
B, Guiberteau T, Louilot A, Sandner G. Prefrontal dopamine
release and sensory-specific satiety altered in rats with
neonatal ventral hippocampal lesions. Behav Brain Res . 2012
May 16 ; 231(1):97-104. Abstract
|
|
|
 |
|
 |